Literature DB >> 28117337

Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects.

Paul Faulkner1, Dara G Ghahremani1, Rachel F Tyndale2,3, Chelsea M Cox1, Ari S Kazanjian1, Neil Paterson4, Shahrdad Lotfipour1, Gerhard S Hellemann1, Nicole Petersen1, Celia Vigil1, Edythe D London1.   

Abstract

The use of cigarettes delivering different nicotine doses allows evaluation of the contribution of nicotine to the smoking experience. We compared responses of 46 young adult smokers to research cigarettes, delivering 0.027, 0.110, 0.231, or 0.763 mg nicotine, and conventional cigarettes. On five separate days, craving, withdrawal, affect, and sustained attention were measured after overnight abstinence and again after smoking. Participants also rated each cigarette, and the nicotine metabolite ratio (NMR) was used to identify participants as normal or slow metabolizers. All cigarettes equally alleviated craving, withdrawal, and negative affect in the whole sample, but normal metabolizers reported greater reductions of craving and withdrawal than slow metabolizers, with dose-dependent effects. Only conventional cigarettes and, to a lesser degree, 0.763-mg nicotine research cigarettes increased sustained attention. Finally, there were no differences between ratings of lower-dose cigarettes, but the 0.763-mg cigarettes and (even more so) conventional cigarettes were rated more favorably than lower-dose cigarettes. The findings indicate that smoking-induced relief of craving and withdrawal reflects primarily non-nicotine effects in slow metabolizers, but depends on nicotine dose in normal metabolizers. By contrast, relief of withdrawal-related attentional deficits and cigarette ratings depend on nicotine dose regardless of metabolizer status. These findings have bearing on the use of reduced-nicotine cigarettes to facilitate smoking cessation and on policy regarding regulation of nicotine content in cigarettes. They suggest that normal and slow nicotine metabolizers would respond differently to nicotine reduction in cigarettes, but that irrespective of metabolizer status, reductions to <0.763 mg/cigarette may contribute to temporary attentional deficits.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28117337      PMCID: PMC5518898          DOI: 10.1038/npp.2017.18

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  44 in total

1.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.

Authors:  Delia Dempsey; Piotr Tutka; Peyton Jacob; Faith Allen; Kerri Schoedel; Rachel F Tyndale; Neal L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2004-07       Impact factor: 6.875

2.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence.

Authors:  Karl Fagerström
Journal:  Nicotine Tob Res       Date:  2011-10-24       Impact factor: 4.244

Review 3.  Effects of abstinence from tobacco: valid symptoms and time course.

Authors:  John R Hughes
Journal:  Nicotine Tob Res       Date:  2007-03       Impact factor: 4.244

Review 4.  Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking.

Authors:  J E Rose; E D Levin
Journal:  Br J Addict       Date:  1991-05

5.  Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.

Authors:  F Patterson; R A Schnoll; E P Wileyto; A Pinto; L H Epstein; P G Shields; L W Hawk; R F Tyndale; N Benowitz; C Lerman
Journal:  Clin Pharmacol Ther       Date:  2008-04-02       Impact factor: 6.875

6.  Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.

Authors:  J Foulds; J Stapleton; J Swettenham; N Bell; K McSorley; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

7.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

8.  A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome.

Authors:  Adam M Leventhal; Andrew J Waters; Eric T Moolchan; Stephen J Heishman; Wallace B Pickworth
Journal:  Addict Behav       Date:  2010-08-10       Impact factor: 3.913

9.  Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate.

Authors:  Mary Falcone; Wen Cao; Leah Bernardo; Rachel F Tyndale; James Loughead; Caryn Lerman
Journal:  Biol Psychiatry       Date:  2015-11-26       Impact factor: 13.382

Review 10.  Predictive reward signal of dopamine neurons.

Authors:  W Schultz
Journal:  J Neurophysiol       Date:  1998-07       Impact factor: 2.714

View more
  17 in total

1.  Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.

Authors:  Stephen T Higgins; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Andrea C Villanti; John R Hughes; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Jeff S Priest; Joan M Skelly; Derek D Reed; Janice Y Bunn; Morgan A Tromblee; Christopher A Arger; Mollie E Miller
Journal:  Prev Med       Date:  2018-04-04       Impact factor: 4.018

2.  Behavioral and neural markers of cigarette-craving regulation in young-adult smokers during abstinence and after smoking.

Authors:  Dara G Ghahremani; Paul Faulkner; Chelsea M Cox; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

3.  Reduced Nicotine Content Cigarettes and Cannabis Use in Vulnerable Populations.

Authors:  Maria A Parker; Joanna M Streck; Cecilia L Bergeria; Janice Y Bunn; Diann E Gaalema; Danielle R Davis; Anthony J Barrows; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Stephen T Higgins
Journal:  Tob Regul Sci       Date:  2018-09

4.  Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.

Authors:  Sarah S Dermody; F Joseph McClernon; Neal Benowitz; Xianghua Luo; Jennifer W Tidey; Tracy T Smith; Ryan Vandrey; Dorothy Hatsukami; Eric C Donny
Journal:  Exp Clin Psychopharmacol       Date:  2018-03-05       Impact factor: 3.157

5.  Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations.

Authors:  Rachel N Cassidy; Suzanne M Colby; Jennifer W Tidey; Kristina M Jackson; Patricia A Cioe; Suchitra Krishnan-Sarin; Dorothy Hatsukami
Journal:  Drug Alcohol Depend       Date:  2018-05-16       Impact factor: 4.492

6.  Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial.

Authors:  Rachel N Cassidy; Jennifer W Tidey; Qing Cao; Suzanne M Colby; Francis J McClernon; Joseph S Koopmeiners; Dorothy Hatsukami; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2019-06-21       Impact factor: 4.244

7.  A Pilot Study of E-Cigarette Naïve Cigarette Smokers and the Effects on Craving After Acute Exposure to E-Cigarettes in the Laboratory.

Authors:  Richard De La Garza; Samuel L Shuman; Luba Yammine; Jin Ho Yoon; Ramiro Salas; Manuela Holst
Journal:  Am J Addict       Date:  2019-05-08

8.  Acute subjective sensory perceptions predict relative reinforcing effects of smoked nicotine.

Authors:  Joshua L Karelitz; Kenneth A Perkins
Journal:  Addict Behav       Date:  2021-01-15       Impact factor: 4.591

9.  Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.

Authors:  Dorothy K Hatsukami; Dongqun Xu; Geoffrey Ferris Wayne
Journal:  Nicotine Tob Res       Date:  2022-03-01       Impact factor: 5.825

10.  Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers.

Authors:  Paul Faulkner; Nicole Petersen; Dara G Ghahremani; Chelsea M Cox; Rachel F Tyndale; Gerhard S Hellemann; Edythe D London
Journal:  Psychopharmacology (Berl)       Date:  2017-10-11       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.